In this Issue
The Importance of Sleep
GUEST MEDICAL EDITOR’S PAGE
Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
By Logan Schneider, MD
COVER FOCUS: THE IMPORTANCE OF SLEEP
Sleep characterization in children may have a role in evaluation for risk of impaired development, behavior, mood, and self-regulation.
By Anne M. Morse, DO
Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.
By Raman K. Malhotra, MD
Elite athletes commonly have sleep disturbances and poor sleep quality made worse by the environmental demands of athletics.
By Scott Kutscher, MD
“If sleep doesn’t serve an absolutely vital function, it is the greatest mistake evolution ever made.”—Allan Rechschaffen, University of Chicago
By Michael Howell, MD, FAAN, FAASM
Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.
By Fiona Barwick, PhD
A daily adequate dose of healthy sleep is the most effective performance enhancement on the planet.
With Mathias Basner, MD, PhD, MSc
Sleep disorders are a common symptom of traumatic brain injury and treating them is also part of promoting recovery.
With Michael S. Jaffee, MD, FAAN
New treatments hold promise of increasing efficacy with precision medicine.
By Tyler M. Pugeda, BA; Charlene E. Gamaldo, MD, FAAN, FAASM; and Rachel Marie E. Salas, MD, MEdHP, FAAN
CLINICAL DECISION MAKING: Managing blood pressure after acute ischemic stroke requires different approaches before and after reperfusion.
By Zachary Bulwa, MD; Camilo R. Gomez, MD, MBA; Sarkis Morales-Vidal, MD; and José Biller, MD
Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.
By Riley Bove, MD, MMSc; and Valerie J. Block, DPTSc, PT
This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson’s disease, multiple system atrophy, and dementia with Lewy bodies.
By Ahmad Alsibai, MD; and Jill M. Giordano Farmer, DO
There are knowns, unknowns, and bogeymen.
By Peter McAllister, MD
Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.
By Ari A. Shemesh, MD; and Daniel R. Gold, DO
When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.
By Amanda E. Simon, BS; and Daniel L. Menkes, MD
Answers from attendees of the International Stroke Conference in Honolulu, HI, Feb 6th-8th, 2019.